Cipher Pharmaceuticals to release Q3 results Nov. 6

Mr. Graham Farrell reports CIPHER PHARMACEUTICALS SCHEDULES Q3 2025 EARNINGS RELEASE AND CONFERENCE CALL Cipher Pharmaceuticals Inc. will release its financial results for the third quarter of 2025 after the market close on Thursday, Nov. 6, 2025. The company will also hold a conference call on Friday, Nov. 7, 2025, at 8:30 a.m. ET, to discuss the results and corporate developments. Conference call details Date:  Friday, Nov. 7, 2025 Time:  8:30 a.m. ET Dial-in number:  416-945-7677 or 888-699-1199 Replay:  289-819-1450 or 888-660-6345 Code:  24367 followed by the pound key Expires:  Nov. 14, 2025 Webcast:  A webcast will be available. About Cipher Pharmaceuticals Inc. Cipher Pharmaceuticals is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early- to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the United States and South America.